COPD trials in Moldova

2 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

  Where

  Chisinau

  Age

  40 years to 85 years

  People

  600 worldwide

  Run by

  Expedition Therapeutics, Inc

  See details and how to joinNCT07684820
• Phase 3Enrolling by invitation
  Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency

  Where

  Chisinau

  Age

  20 years to 72 years

  People

  290 worldwide

  Run by

  Grifols Therapeutics LLC

  See details and how to joinNCT02796937